Surescripts Wants DC Circ. To Review FTC Antitrust Suit
Electronic prescription service Surescripts says the D.C. Circuit needs to weigh in on two key questions before the Federal Trade Commission's case accusing it of using contract terms to illegally maintain...To view the full article, register now.
Already a subscriber? Click here to view full article